Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arbutus Biopharma Corp ABUS

Healthcare Biotechnology
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is leveraging its virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can potentially be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV) infection. Its HBV product pipeline includes Imdusiran and AB-101. Imdusiran... see more

Recent & Breaking News (NDAQ:ABUS)

Arbutus Reports First Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire May 6, 2019

Arbutus to Report First Quarter 2019 Financial Results

GlobeNewswire April 29, 2019

Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives

GlobeNewswire March 7, 2019

Arbutus to Report Fourth Quarter and Year-End 2018 Financial Results and Provide Corporate Update

GlobeNewswire February 28, 2019

Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire February 4, 2019

New Research Coverage Highlights Nokia, SecureWorks, National Western Life Group, Brookfield Asset Management, FormFactor, and Arbutus Biopharma — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire December 11, 2018

Arbutus Appoints Dr. Frank Torti as Chairman of its Board of Directors

GlobeNewswire November 26, 2018

Arbutus Reports 2018 Third Quarter Financial Results and Provides Corporate Update

GlobeNewswire November 7, 2018

Arbutus to Report Third Quarter 2018 Financial Results

GlobeNewswire October 31, 2018

Arbutus Names New Members to its Board of Directors

GlobeNewswire October 22, 2018

Arbutus Provides Update on HBV Development Programs and Announces Appointment of Dr. Gaston Picchio as Chief Development Officer

GlobeNewswire October 9, 2018

Arbutus to Present at Chardan’s Genetic Medicines Conference

GlobeNewswire October 2, 2018

Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference

GlobeNewswire August 28, 2018

Consolidated Research: 2018 Summary Expectations for GSV Capital, NantHealth, Gold Fields, Sogou Inc. Sponsored ADR, Clementia Pharmaceuticals, and Arbutus Biopharma — Fundamental Analysis, Key Performance Indications

GlobeNewswire August 21, 2018

Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO™ (patisiran), for the Treatment of ATTR Amyloidosis

GlobeNewswire August 13, 2018

Arbutus to Present at the 2018 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 9, 2018

Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update

GlobeNewswire August 2, 2018

Arbutus to Report Second Quarter 2018 Financial Results

GlobeNewswire July 19, 2018

Arbutus Presents Corporate Update on Key Milestones

GlobeNewswire July 10, 2018

Arbutus Biopharma to Present at First Annual Roivant Pipeline Day

GlobeNewswire June 18, 2018